BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26851200)

  • 1. Modulation of nucleus accumbens connectivity by alcohol drinking and naltrexone in alcohol-preferring rats: A manganese-enhanced magnetic resonance imaging study.
    Dudek M; Canals S; Sommer WH; Hyytiä P
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):445-55. PubMed ID: 26851200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain activation induced by voluntary alcohol and saccharin drinking in rats assessed with manganese-enhanced magnetic resonance imaging.
    Dudek M; Abo-Ramadan U; Hermann D; Brown M; Canals S; Sommer WH; Hyytiä P
    Addict Biol; 2015 Nov; 20(6):1012-21. PubMed ID: 25146961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.
    Koistinen M; Tuomainen P; Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1605-12. PubMed ID: 11707635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats.
    Oliva JM; Manzanares J
    Neuropsychopharmacology; 2007 Jun; 32(6):1358-69. PubMed ID: 17063152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol preference and consumption are controlled by the caudal linear nucleus in alcohol-preferring rats.
    Dudek M; Hyytiä P
    Eur J Neurosci; 2016 Jun; 43(11):1440-8. PubMed ID: 27038036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.
    Cowen MS; Rezvani AH; Jarrott B; Lawrence AJ
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1008-14. PubMed ID: 10397284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system.
    Lee YK; Park SW; Kim YK; Kim DJ; Jeong J; Myrick H; Kim YH
    Alcohol Alcohol; 2005; 40(4):297-301. PubMed ID: 15897221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats.
    Uhari-Väänänen J; Eteläinen T; Bäckström P; Oinio V; Carroll FI; Raasmaja A; Kiianmaa K; Piepponen P
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1386-1396. PubMed ID: 31679889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone.
    Coonfield DL; Kiefer SW; Ferraro FM; Sinclair JD
    Behav Neurosci; 2004 Oct; 118(5):1089-96. PubMed ID: 15506891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
    Kato H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats.
    Uhari-Väänänen J; Raasmaja A; Bäckström P; Oinio V; Carroll FI; Airavaara M; Kiianmaa K; Piepponen P
    Psychopharmacology (Berl); 2018 May; 235(5):1581-1591. PubMed ID: 29492614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.
    Sabino V; Kwak J; Rice KC; Cottone P
    Alcohol Clin Exp Res; 2013 Apr; 37(4):635-43. PubMed ID: 23126554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex.
    Echeverry-Alzate V; Tuda-Arízcun M; Bühler KM; Santos Á; Giné E; Olmos P; Gorriti MÁ; Huertas E; Rodríguez de Fonseca F; López-Moreno JA
    Neuropharmacology; 2012 Nov; 63(6):927-35. PubMed ID: 22749946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of nucleus accumbens dopamine D1 receptor blockade on consumption during the first two days of operant self-administration of sweetened ethanol in adult Long-Evans rats.
    Doherty JM; Gonzales RA
    Alcohol; 2015 Sep; 49(6):543-51. PubMed ID: 26142563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging reveals functionally distinct neuronal networks associated with high-level alcohol consumption in two genetic rat models.
    Pallarés V; Dudek M; Moreno A; Pérez-Ramírez Ú; Moratal D; Haaranen M; Ciccocioppo R; Sommer WH; Canals S; Hyytiä P
    Behav Pharmacol; 2021 Apr; 32(2&3):229-238. PubMed ID: 32925226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone.
    Dayas CV; Liu X; Simms JA; Weiss F
    Biol Psychiatry; 2007 Apr; 61(8):979-89. PubMed ID: 17098214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.